Key Partnerships

Roivant Sciences has established several key partnerships as part of its business model to drive innovation and accelerate the development of new therapeutics. These partnerships play a crucial role in bringing together complementary expertise and resources to advance drug development and improve patient outcomes.

Roivant Sciences collaborates with leading research institutions to access cutting-edge scientific expertise and technologies. These partnerships help Roivant identify novel drug targets, validate drug candidates, and advance the development of new therapies. By leveraging the expertise of academic researchers, Roivant is able to accelerate its drug development programs and bring new treatments to patients more quickly.

Roivant Sciences forms strategic alliances with pharmaceutical companies to leverage their drug development expertise, resources, and capabilities. These partnerships enable Roivant to access additional funding, infrastructure, and expertise to advance its pipeline of therapeutic candidates. By partnering with established pharmaceutical companies, Roivant can tap into their global networks, regulatory experience, and commercial capabilities to bring new drugs to market more efficiently.

Roivant Sciences enters into licensing agreements with technology providers and biotech companies to access innovative platforms, technologies, and drug candidates. These agreements allow Roivant to expand its pipeline of therapeutic candidates, diversify its portfolio, and explore new therapeutic modalities. By licensing cutting-edge technologies and drug candidates, Roivant can accelerate the development of novel treatments and address unmet medical needs in various therapeutic areas.

• Roivant Sciences partners with healthcare providers to conduct clinical trials, recruit patients, and access real-world data for research purposes. These partnerships help Roivant gather valuable insights into disease mechanisms, treatment outcomes, and patient preferences to inform its drug development strategies.
• Roivant also collaborates with insurance companies to gather real-world evidence on treatment outcomes, healthcare utilization, and patient outcomes. These partnerships help Roivant demonstrate the value of its therapies, secure reimbursement, and improve patient access to innovative treatments.

Overall, Roivant Sciences' key partnerships play a critical role in advancing its mission to develop transformative therapies for patients and improve healthcare outcomes. By collaborating with research institutions, pharmaceutical companies, technology providers, healthcare providers, and insurance companies, Roivant can leverage their expertise, resources, and networks to accelerate drug development, commercialization, and patient access.

Key Activities

Key Resources

Roivant Sciences possesses a range of key resources that contribute to its success in the biopharmaceutical industry. These resources enable the company to conduct cutting-edge scientific research, develop innovative drugs, and bring them to market efficiently.

• Scientific and clinical research team: Roivant Sciences has assembled a team of highly skilled and experienced scientists, researchers, and clinicians who are experts in their respective fields. This team works tirelessly to discover new drugs, conduct preclinical and clinical trials, and bring promising therapies to patients.
• Intellectual property: The company holds a significant portfolio of patents covering its proprietary drugs and technologies. These patents provide Roivant Sciences with exclusive rights to develop, manufacture, and market its products, giving it a competitive advantage in the market.
• State-of-the-art laboratories and research facilities: Roivant Sciences invests heavily in state-of-the-art laboratories and research facilities equipped with the latest technologies and tools. These facilities enable the company to conduct experiments, analyze data, and develop novel treatments effectively.
• Capital for research, development, and marketing: Roivant Sciences has access to capital from investors, partners, and revenue streams to fund its research, development, and marketing efforts. This financial support allows the company to pursue ambitious projects, advance its pipeline of drugs, and promote its products to healthcare providers and patients.

Value Propositions

Roivant Sciences is dedicated to providing innovative medicines for untreatable and rare diseases. Our focus on developing groundbreaking therapies for conditions that have previously had limited treatment options sets us apart in the pharmaceutical industry. By targeting these underserved populations, we are able to make a significant impact on improving patient outcomes and quality of life.

One of our key value propositions is our ability to streamline the drug development process, leading to faster times to market for new treatments. Through strategic partnerships and innovative research practices, we are able to expedite the development of new drugs, bringing them to patients more quickly than traditional pharmaceutical companies.

Additionally, Roivant Sciences is committed to patient-centered healthcare technologies that empower individuals to take control of their own health. By leveraging cutting-edge technology, we are able to provide patients with tools and resources to manage their conditions more effectively, ultimately leading to improved outcomes.

Our focus on improving the lives of patients extends beyond just treating their diseases. We strive to enhance overall quality of life for individuals by providing comprehensive support and resources to address the holistic needs of each patient. By taking a multidisciplinary approach to healthcare, we are able to offer a more personalized and effective treatment experience.

• Offering innovative medicines for untreatable and rare diseases
• Reducing development times for new drugs
• Providing patient-centered healthcare technologies
• Improving outcomes and quality of life for patients

Customer Relationships

Roviant Sciences understands the importance of building strong relationships with its customers in order to provide the best healthcare solutions. Here are some key strategies for maintaining and enhancing customer relationships:

• Direct Engagement: Roviant Sciences actively engages with patient advocacy groups to better understand the needs and challenges of patients. This direct engagement helps the company tailor its products and services to meet the specific needs of patients.
• Collaboration with Healthcare Professionals: By collaborating with healthcare professionals, Roviant Sciences gains valuable feedback on its products and services. This feedback allows the company to continuously improve and refine its offerings to better serve patients.
• Customer Support: Roviant Sciences provides dedicated customer support for both patients and healthcare providers. This support system ensures that customers have access to the help and information they need, contributing to a positive customer experience.
• Online Platforms: Roviant Sciences offers online platforms for education and resources. These platforms provide valuable information to customers, helping them make informed decisions about their healthcare needs.

By prioritizing direct engagement, collaboration, customer support, and online resources, Roviant Sciences aims to foster strong and lasting relationships with its customers, ultimately improving healthcare outcomes.

Channels

Roivant Sciences utilizes a variety of channels to reach its target customers and distribute its products effectively. These channels include:

• Direct sales to healthcare providers and hospitals: One of the primary channels for Roivant Sciences is direct sales to healthcare providers and hospitals. The company has sales teams that engage with healthcare professionals to promote and sell their products.
• Online sales through company website: Roivant Sciences also sells its products directly to customers through its company website. This channel allows for convenient access to their products for healthcare providers as well as patients.
• Distribution through pharmaceutical wholesalers: To reach a wider network of customers, Roivant Sciences works with pharmaceutical wholesalers to distribute their products to pharmacies and healthcare facilities across the country. This channel ensures that their products are available in various locations.
• Collaborative agreements with pharmacies and clinics: Roivant Sciences also has collaborative agreements with pharmacies and clinics to promote and distribute their products. These partnerships help increase the reach and accessibility of Roivant Sciences' products to patients who need them.

Customer Segments

The primary customer segments for Roivant Sciences include:

• Patients with rare and untreatable diseases: Roivant Sciences focuses on developing innovative treatments for rare and untreatable diseases that have limited treatment options available. These patients are often underserved by traditional pharmaceutical companies, and Roivant aims to provide them with life-changing therapies.
• Healthcare providers and professionals: Roivant works closely with healthcare providers and professionals to ensure the safe and effective delivery of their treatments. This segment includes physicians, nurses, pharmacists, and other healthcare professionals who play a crucial role in the care of patients with rare diseases.
• Research institutions and academic centers: Roivant collaborates with research institutions and academic centers to advance scientific knowledge and develop new treatments for rare diseases. These institutions often provide valuable insights and resources that contribute to the success of Roivant's projects.
• Pharmaceutical and biotechnology companies: Roivant also partners with pharmaceutical and biotechnology companies to leverage their expertise, resources, and infrastructure in drug development. These collaborations allow Roivant to bring their products to market more efficiently and effectively.

Cost Structure

Roivant Sciences operates in the pharmaceutical industry, where high research and development costs are a significant part of the business model. The cost structure of the company includes:

• High research and development expenses: Roivant Sciences invests heavily in research and development to discover and develop new treatments for unmet medical needs. This includes funding for research labs, scientists, equipment, and clinical studies.
• Clinical trials and regulatory approval costs: Bringing a new drug to market requires conducting clinical trials to demonstrate safety and efficacy to regulatory agencies like the FDA. These trials can be costly and time-consuming, adding to the overall cost structure of the company.
• Marketing and sales expenses: Once a drug is approved, Roivant Sciences incurs expenses related to marketing and sales efforts to promote the product to healthcare providers and patients. This includes advertising, sales representatives, and distribution costs.
• Operations and administrative costs: Running a pharmaceutical company involves various operational and administrative expenses such as salaries, office space, IT infrastructure, legal fees, and compliance costs. These costs are necessary to support the day-to-day operations of the business.

Revenue Streams

Roivant Sciences generates revenue through various streams, leveraging its innovative drugs and technologies to drive financial growth.

Sales of proprietary drugs and technologies: The primary revenue stream for Roivant Sciences comes from the sales of its proprietary drugs and technologies. These drugs are developed in-house and marketed to target patient populations. With a focus on unmet medical needs, Roivant Sciences brings unique solutions to the market, generating revenue through the sale of these life-saving treatments.

Licensing fees and royalties from partnerships: Roivant Sciences also generates revenue through licensing fees and royalties from partnerships with other pharmaceutical companies. By leveraging its technology and intellectual property, Roivant Sciences can enter into collaborations that provide a steady stream of income through licensing agreements and royalty payments.

Government and private grants for research: Another revenue stream for Roivant Sciences comes from government and private grants for research. These grants provide funding for the development of new drugs and technologies, allowing Roivant Sciences to conduct groundbreaking research without bearing the full financial burden.

Income from strategic collaborations and joint ventures: Roivant Sciences also generates income from strategic collaborations and joint ventures with other companies in the healthcare industry. By partnering with established organizations, Roivant Sciences can access new markets, expand its product pipeline, and drive revenue growth through shared resources and expertise.

• Sales of proprietary drugs and technologies
• Licensing fees and royalties from partnerships
• Government and private grants for research
• Income from strategic collaborations and joint ventures